Procurement of One (1) Li-COR Odyssey M Imaging System, or Equivalent, for the Urologic Oncology Branch
Closed Solicitation Posted
- Solicitation number
- 75N91022Q00161
- Agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
Notice details come from SAM.gov. Updated .
Notice text
The U.S. Department of Health and Human Services (HHS), National Institutes of Health (NIH), National Cancer Institute (NCI), Center for Cancer Research (CCR), Urologic Oncology Branch (UOB) requires the procurement of one (1) Li-COR Odyssey M Imaging System, or equivalent to support ongoing research capabilities.
This is a combined synopsis/solicitation for commercial items, prepared in accordance with the format in FAR 12.6 as supplemented with additional information included in this notice, and shall be processed in accordance with FAR Part 13 - Simplified Acquisition Procedures. This announcement constitutes the only solicitation, and a separate written solicitation will not be issued. This solicitation, 75N91022Q00161, is issued as a request for quote (RFQ) and includes all applicable provisions and clauses in effect through FAR Federal Acquisition Circular (FAC) 2022-07 (08-10-2022), simplified acquisition procedures for commercial items.
The North American Industry Classification System code is 334516 and the business size standard is 1,000 employees.
* See attached Combined Synopsis/Solicitation for more details regarding requirements, terms and conditions, and submittal instructions. *
Attachment 1: Combined Synopsis/Solicitation Notice
Attachment 2: FAR 52.212-3
Files
| File | Type | Posted |
|---|---|---|
| Attachment 2_FAR 52.212-3.pdf | ||
| Attachment 1_CombSynp_75N91022Q00161.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity